Esperion Announces the Appointment of Seth H.Z. Fischer to its Board of Directors

ANN ARBOR, Mich., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the appointment of Seth H.Z. Fischer as a Class III director, with a term expiring at

Related Keywords

United States ,America ,Sheldon Koenig ,Sethhz Fischer ,Cordis Corporation ,Biosig Technologies Inc ,Mcneil Pharmaceuticals ,Twitter ,Vivus Inc ,Us Air ,Lipid Management Company ,Marinus Pharmaceuticals ,Exchange Commission ,Ohio University ,Agile Therapeutics Inc ,Spectrum Pharmaceuticals Inc ,America Pharmaceuticals ,Johnson ,Agile Therapeutics ,Spectrum Pharmaceuticals ,North America Pharmaceuticals ,Ortho Mcneil Pharmaceuticals ,From May ,Biosig Technologies ,General Studies ,Therapeutics Esperion ,Lipid Management ,Looking Statements This ,Esperion Media ,Money ,Ational ,